Chemicals & Advanced Materials Global On demand · 24-48h

Global IMAC Resin Market Strategic Research Report

Global IMAC Resin Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global IMAC Resin Market
$1852025
7.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Nickel Charged, Cobalt Charged, Copper Charged, Zinc Charged, Uncharged Chelating, Other Metal Charged

By Application: Research Protein Purification, Biopharma Process Development, Recombinant Protein Manufacturing, Enzyme and Peptide Purification, High-Throughput Screening, Analytical Sample Preparation, Other Protein Capture

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Cytiva, Bio-Rad, Thermo Fisher Scientific, Qiagen, Merck KGaA, Takara Bio, Bio-Works, Tosoh Bioscience, Sepax Technologies, BestChrom, Smart-Lifesciences, Agarose Bead Technologies, Cube Biotech, GenScript, GoldBio, G-Biosciences, New England Biolabs, Macherey-Nagel, SERVA Electrophoresis, Jena Bioscience, Protein Ark, Beyotime Biotechnology, Yeasen Biotechnology, Marvelgent Biosciences

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 146 pages
Market size 2025
$185
Million USD
Forecast CAGR
7.4%
2025-2032
Forecast 2032
$304.9
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global IMAC Resin market size is predicted to grow from US$ 185 million in 2025 to US$ 303 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

IMAC resin is an affinity chromatography medium composed of agarose, polymer, silica, or magnetic particles as the matrix, functionalized with metal-chelating ligands such as NTA, IDA, or TED, and pre-loaded or in-situ loaded with transition metal ions including Ni²⁺, Co²⁺, Cu²⁺, and Zn²⁺. It is primarily used for the capture, purification, and process scale-up of His-tagged recombinant proteins, histidine- or cysteine-rich proteins, and certain peptides. Estimated gross margin is approximately 55%.

IMAC resin unit prices are significantly lower than Protein A resins, but the SKU range is wide, customers are dispersed, and consumption frequency is stable, resulting in a market that is not large but resilient.

Demand is driven by recombinant protein expression experiments in universities and research institutions, process screening at CROs/CDMOs, early-stage biopharmaceutical development, and industrial enzyme production. Ni-NTA remains the mainstream format; cobalt, TED, and higher-rigidity matrix products cater to higher purity requirements, better tolerance to reducing agents/chelators, or higher flow rate scenarios, with clear pricing tiers. With the growth of synthetic biology, recombinant collagen, cytokines, enzyme preparations, and diagnostic antigen production, IMAC has gradually extended from disposable lab consumables to small- and mid-scale process consumables.

The supply side is structured in two tiers: international brands such as Cytiva, Bio-Rad, Thermo Fisher, Qiagen, and Merck dominate high-end research and process validation channels, while Chinese and European SMEs enter with cost-effective bulk resins, pre-packed columns, and magnetic beads. Future growth will mainly come from domestic substitution, customized metal ion/ligand combinations, high-throughput automated purification formats, and integration with downstream chromatography kits, rather than pure expansion of laboratory usage.

Key Questions Addressed in this Report

What is the 10-year outlook for the global IMAC Resin market?

What factors are driving IMAC Resin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do IMAC Resin market opportunities vary by end market size?

How does IMAC Resin break out by Type, by Application?

This report presents a comprehensive overview of the global IMAC Resin market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Nickel Charged
  • Cobalt Charged
  • Copper Charged
  • Zinc Charged
  • Uncharged Chelating
  • Other Metal Charged

Segment by Chelator Type

  • NTA Chelator
  • IDA Chelator
  • TED Chelator
  • Proprietary Chelator
  • Other or Undisclosed

Segment by Matrix Type

  • Nonmagnetic Agarose
  • Rigid Polymer
  • Silica or Hybrid
  • Magnetic Particle
  • Other Matrix

Segment by Delivery Format

  • Loose Resin
  • Gravity Column
  • FPLC Cartridge
  • Spin Column or Plate
  • Magnetic Beads
  • Bulk Process Pack
  • Other Format

Segment by Application

  • Research Protein Purification
  • Biopharma Process Development
  • Recombinant Protein Manufacturing
  • Enzyme and Peptide Purification
  • High-Throughput Screening
  • Analytical Sample Preparation
  • Other Protein Capture

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global IMAC Resin market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Research Protein Purification, Biopharma Process Development, Recombinant Protein Manufacturing evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global IMAC Resin Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$185
2025
Forecast
$304.9
2032
CAGR
7.4%
2025–2032
Regions
5
global
Key companies
CytivaBio-RadThermo Fisher ScientificQiagenMerck KGaATakara BioBio-WorksTosoh Bioscience
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Nickel ChargedCobalt ChargedCopper ChargedZinc ChargedUncharged ChelatingOther Metal Charged
By Application
Research Protein PurificationBiopharma Process DevelopmentRecombinant Protein ManufacturingEnzyme and Peptide PurificationHigh-Throughput ScreeningAnalytical Sample PreparationOther Protein Capture

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Nickel Charged
  • 3.1.3 Cobalt Charged
  • 3.1.4 Copper Charged
  • 3.1.5 Zinc Charged
  • 3.1.6 Uncharged Chelating
  • 3.1.7 Other Metal Charged
  • 3.1.8 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Research Protein Purification
  • 4.1.3 Biopharma Process Development
  • 4.1.4 Recombinant Protein Manufacturing
  • 4.1.5 Enzyme and Peptide Purification
  • 4.1.6 High-Throughput Screening
  • 4.1.7 Analytical Sample Preparation
  • 4.1.8 Other Protein Capture
  • 4.1.9 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Cytiva
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Bio-Rad
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Thermo Fisher Scientific
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Qiagen
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Merck KGaA
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Takara Bio
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Bio-Works
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Tosoh Bioscience
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Sepax Technologies
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 BestChrom
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Smart-Lifesciences
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Agarose Bead Technologies
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Cube Biotech
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 GenScript
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 GoldBio
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 G-Biosciences
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 New England Biolabs
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Macherey-Nagel
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 SERVA Electrophoresis
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Jena Bioscience
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Protein Ark
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Beyotime Biotechnology
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Yeasen Biotechnology
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Marvelgent Biosciences
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global IMAC Resin market?
The global IMAC Resin market is estimated at US$ 185 million in 2025 (base year) and is projected to reach US$ 303 million by 2032.
How fast is the IMAC Resin market expected to grow?
The market is expected to grow at a CAGR of 7.4% from 2026 to 2032, expanding from US$ 185 million in 2025 to US$ 303 million in 2032, roughly 1.6 times its base-year value.
What does the IMAC Resin market cover?
IMAC resin is an affinity chromatography medium composed of agarose, polymer, silica, or magnetic particles as the matrix, functionalized with metal-chelating ligands such as NTA, IDA, or TED, and pre-loaded or in-situ loaded with transition metal ions including Ni²⁺, Co²⁺, Cu²⁺, and Zn²⁺. It is primarily used for the capture, purification, and process scale-up of His-tagged recombinant proteins, histidine- or cysteine-rich proteins, and certain peptides. Estimated gross margin is approximately 55%.
How is the IMAC Resin market segmented by type?
By type, the market is segmented into Nickel Charged, Cobalt Charged, Copper Charged, Zinc Charged, Uncharged Chelating and Other Metal Charged.
What are the key applications of IMAC Resin?
Key applications covered include Research Protein Purification, Biopharma Process Development, Recombinant Protein Manufacturing, Enzyme and Peptide Purification, High-Throughput Screening, Analytical Sample Preparation and Other Protein Capture.
Which companies are profiled in the IMAC Resin market report?
Key players profiled include Cytiva, Bio-Rad, Thermo Fisher Scientific, Qiagen, Merck KGaA, Takara Bio, Bio-Works and Tosoh Bioscience, among 24 companies covered in total.
What geographies does the IMAC Resin market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for IMAC Resin?
Demand is driven by recombinant protein expression experiments in universities and research institutions, process screening at CROs/CDMOs, early-stage biopharmaceutical development, and industrial enzyme production.
Who should buy the IMAC Resin market report?
The report is intended for manufacturers and solution providers, distributors and end users in Research Protein Purification, Biopharma Process Development and Recombinant Protein Manufacturing, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the IMAC Resin market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.